CTi Biopharma Corp 126408HQ9 Bond

CTICDelisted Stock  USD 9.09  0.00  0.00%   
CTi Biopharma's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. CTi Biopharma's financial risk is the risk to CTi Biopharma stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
View Bond Profile
Given the importance of CTi Biopharma's capital structure, the first step in the capital decision process is for the management of CTi Biopharma to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of CTi Biopharma Corp to issue bonds at a reasonable cost.
Popular NameCTi Biopharma US126408HQ95
Equity ISIN CodeUS12648L6011
Bond Issue ISIN CodeUS126408HQ95
S&P Rating
Others
Maturity DateOthers
Issuance DateOthers
View All CTi Biopharma Outstanding Bonds

CTi Biopharma Corp Outstanding Bond Obligations

CSX P 6US126408GH06Details
CSX P 615US126408GK35Details
CSX P 622US126408GS60Details
CSNABZ 4625 10 JUN 31US12644VAD01Details
Boeing Co 2196US097023DG73Details
CSX P 475US126408GW72Details
CSX P 44US126408GX55Details
CSX P 41US126408GY39Details
CSX P 55US126408GU17Details
US126408HA44US126408HA44Details
CSX P 26US126408HE65Details
CSX P 38US126408HF31Details
CSX P 425US126408HG14Details
CSX P 395US126408HC00Details
CSX P 335US126408HD82Details
CSX P 38US126408HJ52Details
CSX P 43US126408HK26Details
CSX P 325US126408HH96Details
CSX P 475US126408HN64Details
CSX P 465US126408HL09Details
CSX P 425US126408HM81Details
US126408HR78US126408HR78Details
US126408HS51US126408HS51Details
US126408HP13US126408HP13Details
US126408HQ95US126408HQ95Details
CSX 45 15 NOV 52US126408HV80Details
US126408HT35US126408HT35Details
CSX 41 15 NOV 32US126408HU08Details
MPLX LP 52US55336VAL45Details
US12641LBU61US12641LBU61Details
US126408BM46US126408BM46Details
US126458AE87US126458AE87Details

Understaning CTi Biopharma Use of Financial Leverage

CTi Biopharma's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures CTi Biopharma's total debt position, including all outstanding debt obligations, and compares it with CTi Biopharma's equity. Financial leverage can amplify the potential profits to CTi Biopharma's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if CTi Biopharma is unable to cover its debt costs.
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington. Cti Biopharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 121 people.
Please read more on our technical analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in CTi Stock

If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Volatility Analysis
Get historical volatility and risk analysis based on latest market data

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.